| Literature DB >> 34371084 |
Melgious Jin Yan Ang1, Siew Yin Chan2, Yi-Yiing Goh1, Zichao Luo3, Jun Wei Lau3, Xiaogang Liu4.
Abstract
Cancer involves a collection of diseases with a common trait - dysregulation in cell proliferation. At present, traditional therapeutic strategies against cancer have limitations in tackling various tumors in clinical settings. These include chemotherapeutic resistance and the inability to overcome intrinsic physiological barriers to drug delivery. Nanomaterials have presented promising strategies for tumor treatment in recent years. Nanotheranostics combine therapeutic and bioimaging functionalities at the single nanoparticle level and have experienced tremendous growth over the past few years. This review highlights recent developments of advanced nanomaterials and nanotheranostics in three main directions: stimulus-responsive nanomaterials, nanocarriers targeting the tumor microenvironment, and emerging nanomaterials that integrate with phototherapies and immunotherapies. We also discuss the cytotoxicity and outlook of next-generation nanomaterials towards clinical implementation.Entities:
Keywords: Drug delivery; Immunotherapy; Nanomedicine; Phototherapy; Stimulus-responsive; Theranostics; Toxicity
Mesh:
Substances:
Year: 2021 PMID: 34371084 DOI: 10.1016/j.addr.2021.113907
Source DB: PubMed Journal: Adv Drug Deliv Rev ISSN: 0169-409X Impact factor: 15.470